Review
Jul 2026
[Advancement of subtype-based early breast cancer systematic therapy].
Molecular subtype-guided precision medicine now enables individualized systemic therapy for EBC via novel agents and biomarker-driven strategies, optimizing clinical decisions and improving outcomes.
S. Liu, G.-J. Zhang, J. Zhang et al.
· Zhonghua yi xue za zhi · 0 citations